KLS Keeping Law Simple Legislation in plain English

Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.

Back to Indiana

SB150 • 2026

A BILL FOR AN ACT to amend the Indiana Code concerning insurance.

A BILL FOR AN ACT to amend the Indiana Code concerning insurance.

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Senator Rodney Pol
Last action
2026-01-05
Official status
Introduced Senate Bill (S)
Effective date
Not listed

Plain English Breakdown

The official source material does not provide information on what happens if the bill does not pass, nor does it address how insurance companies will cover costs beyond $35.

Setting a Price Cap on Insulin

This bill sets a limit on how much money people in Indiana have to pay for their insulin each month.

What This Bill Does

  • Requires insurance companies to cap the total amount an insured person pays for a 30-day supply of prescription insulin drugs at $35, regardless of the number and types of insulin prescribed.

Who It Names or Affects

  • People who need insulin for their diabetes
  • Insurance companies that cover prescription drugs

Terms To Know

Insulin
A medicine used by people with diabetes to control blood sugar levels.
Price cap
The highest amount a company can charge for something, set by law or rules.

Limits and Unknowns

  • Does not cover other prescription drugs besides insulin.
  • Does not explain how insurance companies will pay for the cost of insulin beyond $35.

Bill History

  1. 2026-01-05 Senate

    Authored by Senator Pol

  2. 2026-01-05 Senate

    First reading: referred to Committee on Health and Provider Services

Official Summary Text

A BILL FOR AN ACT to amend the Indiana Code concerning insurance.
Insulin price cap.

Current Bill Text

Read the full stored bill text 
A BILL FOR AN ACT to amend the Indiana Code concerning insurance.

Insulin price cap.

Requires an insurer to cap the total amount an insured is required to pay for a 30 day supply of prescription insulin drugs at an amount not to exceed $35, regardless of the number of prescriptions and different types of insulin prescribed and filled during that period.